0
0
0
A resolution recognizing the seriousness of myotonic dystrophy and expressing support for the designation of September 15, 2022, as "International Myotonic Dystrophy Awareness Day".
12/29/2022, 1:18 PM
Summary of Bill SRES 772
Bill 117 sres 772 is a resolution that acknowledges the severity of myotonic dystrophy, a genetic disorder that affects muscle function and can lead to a range of symptoms including muscle weakness, stiffness, and fatigue. The resolution expresses support for designating September 15, 2022, as "International Myotonic Dystrophy Awareness Day" in order to raise awareness about the condition and its impact on individuals and families.
The resolution highlights the need for increased research and resources to better understand and treat myotonic dystrophy, as well as the importance of providing support and resources for individuals living with the condition. It also recognizes the efforts of organizations and advocates working to raise awareness and improve the lives of those affected by myotonic dystrophy.
Overall, Bill 117 sres 772 aims to bring attention to myotonic dystrophy and the challenges faced by those living with the condition, while also promoting greater understanding and support for individuals and families impacted by this genetic disorder.
The resolution highlights the need for increased research and resources to better understand and treat myotonic dystrophy, as well as the importance of providing support and resources for individuals living with the condition. It also recognizes the efforts of organizations and advocates working to raise awareness and improve the lives of those affected by myotonic dystrophy.
Overall, Bill 117 sres 772 aims to bring attention to myotonic dystrophy and the challenges faced by those living with the condition, while also promoting greater understanding and support for individuals and families impacted by this genetic disorder.
Congressional Summary of SRES 772
This resolution designates September 15, 2022, as International Myotonic Dystrophy Awareness Day. Myotonic dystrophy is an inherited disorder characterized by progressive muscle loss and weakness.
Read the Full Bill
Current Status of Bill SRES 772
Bill SRES 772 is currently in the status of Passed in Senate since September 29, 2022. Bill SRES 772 was introduced during Congress 117 and was introduced to the Senate on September 19, 2022. Bill SRES 772's most recent activity was Resolution agreed to in Senate without amendment and with a preamble by Unanimous Consent. as of September 29, 2022
Bipartisan Support of Bill SRES 772
Total Number of Sponsors
1Democrat Sponsors
1Republican Sponsors
0Unaffiliated Sponsors
0Total Number of Cosponsors
6Democrat Cosponsors
4Republican Cosponsors
2Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill SRES 772
Primary Policy Focus
HealthPotential Impact Areas
- Child health
- Commemorative events and holidays
- Drug therapy
- Health promotion and preventive care
- Hereditary and development disorders
- Medical research
- Musculoskeletal and skin diseases
- Research administration and funding
Alternate Title(s) of Bill SRES 772
A resolution recognizing the seriousness of myotonic dystrophy and expressing support for the designation of September 15, 2022, as "International Myotonic Dystrophy Awareness Day".
A resolution recognizing the seriousness of myotonic dystrophy and expressing support for the designation of September 15, 2022, as "International Myotonic Dystrophy Awareness Day".
Comments
Sponsors and Cosponsors of SRES 772
Latest Bills
RURAL Healthcare Act
Bill HR 8347July 30, 2026
Cancer Drug Parity Act of 2026
Bill S 5004July 30, 2026
BANNED in Latin America Act
Bill S 4665July 30, 2026
Arctic Security and Diplomacy Act
Bill S 4708July 30, 2026
Endless Mountains National Heritage Area Act
Bill S 4238July 30, 2026
Work Without Worry Act of 2026
Bill S 5006July 30, 2026
Douglas County Economic Development and Conservation Act
Bill S 4200July 30, 2026
21st Century ROAD to Housing Act
Bill HR 6644July 30, 2026
Language Access for All Act of 2026
Bill S 4985July 30, 2026
Biotechnology Diplomacy Leadership Act of 2026
Bill HR 9755July 30, 2026



